The FDA is rushing to rubber stamp Gardasil, a cervical cancer vaccine, for women ages 27-45.  Initially, the miracle HPV-preventer has been well received by its intended market—women and girls ages 9-26. Due to Gardasil’s success, amounting in $1.5 billion in sales last year, its makers, Merck & Co, are looking to expand potential beneficiaries. Merck has found Gardasil to be 91% effective in women 24-45 and are pushing for FDA approval within six months. The FDA is already reviewing a similarly effective British vaccine, Cervarix, put out by GlaxoSmithKline PLC, which is currently used for women up to 55 years of age in the U.K. No matter who wins the vaccine approval race, this is good news for women. With 250,000 reported deaths from cervical cancer every year, somethin’ has gotta be done! [ Boston Globe]

Sure the 50-Foot Woman can kick anyone’s butt, but now a new study has shown she’s at a higher risk to have to fight off skin cancer too. According to an Australian scientist, Dr. Catherine Olsen, from the Queensland Institute of Medical Research, the tallest quarter of the 5,000 women she studied were 30% more likely to get melanoma than shorties. Dr. Olsen added, “We found this risk greater among women less than 50 years of age.” Is that just because tall women have more skin to show? Well, she and her colleagues from Italy, the USA, and Britain, are just not sure, but being naturally pasty or excessively tanning are still the strongest risk factors. So ladies, if you want to look trendy and orange like Paris Hilton, but not get the big C, you better stick to a spray tan….or you’ll end up looking like a California Raisin like Lindsay Lohan. [Fox News]